Clinical usefulness of high-dose toremifene in patients relapsed on treatment with an aromatase inhibitor-Reference-Cited by-同舟云学术

Clinical usefulness of high-dose toremifene in patients relapsed on treatment with an aromatase inhibitor

Published:2009-08-15 Issue:4 Volume:17 Page:254-260
ISSN:1340-6868
Container-title:Breast Cancer
language:en
Short-container-title:Breast Cancer

Author:

Yamamoto Yutaka,Masuda Norikazu,Ohtake Tohru,Yamashita Hiroko,Saji Shigehira,Kimijima Izo,Kasahara Yoshio,Ishikawa Takashi,Sawaki Masataka,Hozumi Yasuo,Iwase Hirotaka

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12282-009-0148-2.pdf

Reference22 articles.

1. Iwase H. Current topics and perspectives on the use of aromatase inhibitors in the treatment of breast cancer. Breast Cancer. 2008;15(4):278–90.

2. Hortobagyi GN. Novel approaches to the management of bone metastases in patients with breast cancer. Semin Oncol. 2002;29:134–44.

3. Stenbygaard LE, Herrstedt J, Thomsen JF, Svendsen KR, Engelholm SA, Dombernowsky P. Toremifene and tamoxifen in advanced breast cancer—a double-blind cross-over trial. Breast Cancer Res Treat. 1993;25:57–63.

4. Pyrhonen S, Ellmen J, Vuorinen J, Gershanovich M, Tominaga T, Kaufmann M, et al. Meta-analysis of trials comparing toremifene with tamoxifen and factors predicting outcome of antiestrogen therapy in postmenopausal women with breast cancer. Breast Cancer Res Treat. 1999;56:133–43.

5. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92:205–16.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-Dose Toremifene as a Promising Candidate Therapy for Hormone Receptor-Positive Metastatic Breast Cancer with Secondary Resistance to Aromatase Inhibitors;International Journal of Breast Cancer;2020-02-12

2. Hormone signaling via androgen receptor affects breast cancer and prostate cancer in a male patient: A case report;BMC Cancer;2018-12

3. Fulvestrant 500 mg in postmenopausal patients with metastatic breast cancer: the initial clinical experience;Breast Cancer;2015-04-21

4. High-Dose Toremifene for Fulvestrant-Resistant Metastatic Breast Cancer: A Report of Two Cases;Case Reports in Oncology;2014-06-06

5. Toremifene for Breast Cancer: A Review of 20 Years of Data;Clinical Breast Cancer;2014-02